Mark J Arends
Overview
Explore the profile of Mark J Arends including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
145
Citations
4494
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Yli-Hallila A, Bankhead P, Arends M, Lehenkari P, Palosaari S
J Anat
. 2024 Nov;
PMID: 39555994
Virtual microscopy is becoming increasingly common in both medical education and routine clinical practice. Virtual microscopy software is typically designed either for (1) training students in anatomy, histology, and histopathology,...
2.
Arends M, Del Castillo Velasco-Herrera M, Cheema S, Wong K, Boccacino J, Vermes I, et al.
Br J Dermatol
. 2024 Nov;
PMID: 39546556
No abstract available.
3.
van der Weyden L, Del Castillo Velasco-Herrera M, Cheema S, Wong K, Boccacino J, Vermes I, et al.
Br J Dermatol
. 2024 Nov;
192(3):551-553.
PMID: 39506538
No abstract available.
4.
Basurto-Lozada P, Vazquez-Cruz M, Molina-Aguilar C, Jiang A, Deacon D, Cerrato-Izaguirre D, et al.
medRxiv
. 2024 Oct;
PMID: 39399030
Acral melanoma, which is not ultraviolet (UV)-associated, is the most common type of melanoma in several low- and middle-income countries including Mexico. Latin American samples are significantly underrepresented in global...
5.
van der Weyden L, Del Castillo Velasco-Herrera M, Cheema S, Wong K, Boccacino J, Offord V, et al.
Br J Dermatol
. 2024 Oct;
192(2):335-343.
PMID: 39392932
Background: Cutaneous leiomyosarcoma (cLMS) is a rare soft-tissue neoplasm, showing smooth muscle differentiation, that arises from the mesenchymal cells of the dermis. To date, genetic investigation of these tumours has...
6.
Short E, Adcock I, Al-Sarireh B, Ager A, Ajjan R, Akbar N, et al.
medRxiv
. 2024 Sep;
PMID: 39281746
Background: Around the world, individuals are living longer, but an increased average lifespan does not always equate to an increased healthspan. With advancing age, the increased prevalence of ageing-related diseases...
7.
Churchhouse A, Billard C, Suzuki T, Pohl S, Doleschall N, Donnelly K, et al.
Oncogene
. 2024 Sep;
43(42):3094-3107.
PMID: 39242821
Inflammatory Bowel Disease-associated colorectal cancer (IBD-CRC) is a known and serious complication of Inflammatory Bowel Disease (IBD) affecting the colon. However, relatively little is known about the pathogenesis of IBD-associated...
8.
Southworth E, Thomson J, Croy I, Churchman M, Arends M, Hollis R, et al.
Eur J Cancer
. 2024 Jul;
208:114205.
PMID: 38986422
Introduction: Concurrent non-serous endometrial and ovarian tumours are often managed clinically as two separate primary tumours, but almost all exhibit evidence of a genomic relationship. Methodology: This study investigates the...
9.
Taylor S, Hollis R, Gourley C, Herrington C, Langdon S, Arends M
Exp Mol Pathol
. 2024 Jul;
138:104916.
PMID: 38959632
High-grade serous ovarian cancer (HGSOC) is the most prevalent subtype of ovarian cancer and demonstrates 5-year survival of just 40%. One of the major causes of mortality is the development...
10.
Taylor S, Hollis R, Gourley C, Herrington C, Langdon S, Arends M
Front Oncol
. 2024 May;
14:1389472.
PMID: 38711848
Background: DNA damage repair is frequently dysregulated in high grade serous ovarian cancer (HGSOC), which can lead to changes in chemosensitivity and other phenotypic differences in tumours. RFWD3, a key...